-
Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Nice offer from Nuvasive
Discussion in 'NuVasive' started by Medtronic ASR..., Jun 28, 2010 at 12:03 AM.